Rivastigmine
23 NDCs across 7 manufacturers|17 Generic,6 Brand
Rivastigmine is used to treat alzheimer disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 6, 2007, and the first generic was approved Aug 31, 2015. FDA's Orange Book lists 18 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $79 million on Rivastigmine across 398,000 claims for 82,000 beneficiaries.
Rivastigmine is available as 23 NDCs from 7 manufacturers (17 generic, 6 brand), with NADAC prices from $1.80 to $22.01 per EA — the most expensive product costs about 12× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
23
17G / 6B
Manufacturers
7
competing in market
Price Spread
$1.80 – $22.01
per EA
7d Activity
avg +0.5% WoW · of 23 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
7 manufacturers producing RIVASTIGMINE
Frequently Asked Questions
What is Rivastigmine used to treat?
Rivastigmine is used to treat alzheimer disease, per the National Library of Medicine's MED-RT classification.
When did Rivastigmine become available as a generic?
FDA approved the first generic Rivastigmine (ANDA) on Aug 31, 2015. The Orange Book currently lists 18 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Rivastigmine?
In 2024, Medicare Part D spent $79 million on Rivastigmine across 398,000 claims for 82,000 beneficiaries.
How many Rivastigmine products are on the market?
The Rivastigmine drug market contains 23 NDCs from 7 manufacturers — 17 generic and 6 brand products.
What is the price range for Rivastigmine?
NADAC reference prices for Rivastigmine range from $1.8036 to $22.0078 per EA — the most expensive product costs about 12× the cheapest.
Is generic Rivastigmine cheaper than brand?
The average generic NADAC for Rivastigmine is $1.8158 per EA, versus $21.9006 for brand-labeled products — brand versions average about 12× the generic price.
Which manufacturers make Rivastigmine?
7 manufacturers list Rivastigmine in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (6), Novartis Pharmaceuticals Corporation (3), Zydus Pharmaceuticals (USA) Inc. (3), Mylan Pharmaceuticals Inc. (3), Breckenridge Pharmaceutical Inc. (3).
How has the price of Rivastigmine changed recently?
Over the past 7 days, 11 Rivastigmine NDCs rose and 10 fell, with a market-wide average change of +0.5%.